Back to Search
Start Over
Antibody Response to Symptomatic Infection With SARS‐CoV‐2 Omicron Variant Viruses, December 2021–June 2022.
- Source :
- Influenza & Other Respiratory Viruses; Jul2024, Vol. 18 Issue 7, p1-5, 5p
- Publication Year :
- 2024
-
Abstract
- We describe humoral immune responses in 105 ambulatory patients with laboratory‐confirmed SARS‐CoV‐2 Omicron variant infection. In dried blood spot (DBS) collected within 5 days of illness onset and during convalescence, we measured binding antibody (bAb) against ancestral spike protein receptor binding domain (RBD) and nucleocapsid (N) protein using a commercial multiplex bead assay. Geometric mean bAb concentrations against RBD increased by a factor of 2.5 from 1258 to 3189 units/mL and by a factor of 47 against N protein from 5.5 to 259 units/mL between acute illness and convalescence; lower concentrations were associated with greater geometric mean ratios. Paired DBS specimens may be used to evaluate humoral response to SARS‐CoV‐2 infection. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 17502640
- Volume :
- 18
- Issue :
- 7
- Database :
- Complementary Index
- Journal :
- Influenza & Other Respiratory Viruses
- Publication Type :
- Academic Journal
- Accession number :
- 178647038
- Full Text :
- https://doi.org/10.1111/irv.13339